Aarti Chitale
Aarti Chitale, a Senior Research Analyst at Frost & Sullivan, has 8 years of experience in market research. Her areas of expertise include regenerative medicine, with a keen focus on tracking market and technology trends in cell therapy. In addition to authoring numerous reports in the area of Regenerative Medicine, she has been tracking game-changing companies in this field by identifying some of the disruptive business models such as risk-sharing models, co-development, and fast-to-market models. She earned her MBA in Marketing and International Business from Balaji University, Pune, and her Bachelor’s degree in Biotechnology from Osmania University, Hyderabad.
Aarti Chitale, a Senior Research Analyst at Frost & Sullivan, has 8 years of experience in market research.
Her areas of expertise include regenerative medicine, with a keen focus on tracking market and technology trends in cell therapy. In addition to authoring numerous reports in the area of Regenerative Medicine, she has been tracking game-changing companies in this field by identifying some of the disruptive business models such as risk-sharing models, co-development, and fast-to-market models.
She earned her MBA in Marketing and International Business from Balaji University, Pune, and her Bachelor’s degree in Biotechnology from Osmania University, Hyderabad.
See more
Her areas of expertise include regenerative medicine, with a keen focus on tracking market and technology trends in cell therapy. In addition to authoring numerous reports in the area of Regenerative Medicine, she has been tracking game-changing companies in this field by identifying some of the disruptive business models such as risk-sharing models, co-development, and fast-to-market models.
She earned her MBA in Marketing and International Business from Balaji University, Pune, and her Bachelor’s degree in Biotechnology from Osmania University, Hyderabad.
Articles: Aarti Chitale
Precision Medicine and its Impact on the Global Therapeutic Landscape
Opinion / Frost & Sullivan’s Senior Research Analyst, Aarti Chitale looks at the sizeable impact that precision medicine, especially regenerative medicine, is already having on the global therapeutic landscape, and how the Asia-Pacific region is positioning itself at the forefront of this trend. Providing the right treatment/ right drug at the right time to the right…
Latest Report
